Filter
5870
Filtered Results: 5870
Text search:
National
Medicines
Policy
Featured
Recommendations
473
New Publications
1570
Language
Document type
No document type
3303
Studies & Reports
1104
Guidelines
706
Manuals
304
Strategic & Response Plan
219
Training Material
90
Fact sheets
73
Situation Updates
40
Resource Platforms
12
Brochures
7
Online Courses
6
Infographics
5
App
1
Countries / Regions
India
243
Global
214
Kenya
186
South Africa
139
Uganda
128
Ethiopia
128
Nepal
123
Western and Central Europe
115
Nigeria
111
Latin America and the Carribbean
100
Sierra Leone
99
Malawi
95
Liberia
95
Tanzania
87
Africa
83
Bangladesh
81
Myanmar / Burma
81
Zambia
78
Ghana
77
Ukraine
71
Rwanda
67
Eastern Europe
51
Syria
47
Namibia
46
Zimbabwe
45
South–East Asia Region
45
Philippines
42
Asia
36
Lesotho
35
Venezuela
34
Congo, Democratic Republic of
34
Paraguay
32
Mozambique
31
Russia
30
Colombia
28
Cambodia
28
Indonesia
28
Senegal
26
Guinea
26
Brazil
26
Burkina Faso
23
Botswana
23
South Sudan
23
Peru
22
Haiti
22
West and Central Africa
22
Cameroon
21
East and Southern Africa
21
Yemen
20
Germany
19
Middle East and North Africa
19
Eswatini/ Swaziland
19
Eastern Europe and Central Asia
16
Pakistan
16
Benin
15
Afghanistan
15
Bolivia
14
Sudan
14
Ecuador
14
Thailand
13
Moldova
13
Chile
11
USA
11
Vietnam
11
Lebanon
10
Sri Lanka
10
Somalia
10
Madagascar
10
Tajikistan
9
Jordan
9
Western Pacific Region
9
China
8
Albania
8
North America
8
North Macedonia
7
Mexico
7
Southern Africa
7
Georgia
7
Mali
7
El Salvador
6
Laos
6
Poland
6
Iraq
6
Turkey
5
Iran
5
Kyrgyzstan
5
United Kingdom
5
Argentina
5
Central African Republic
5
Libya
5
Kazakhstan
4
Canada
4
Burundi
4
Hungary
4
Saudi Arabia
4
Papua New Guinea
4
Egypt
4
Romania
4
Palestine
4
Timor Leste/ East Timor
3
Gambia
3
Fiji
3
Estonia
3
Morocco
3
Jamaica
3
Mauritius
3
Spain
3
Belarus
3
Côte d’Ivoire / Ivory Coast
3
Angola
3
Bhutan
3
Serbia
2
Niger
2
Qatar
2
Bulgaria
2
Armenia
2
Guinea-Bissau
2
Lithuania
2
Gabon
2
Turkmenistan
2
Japan
2
France
2
Tunisia
2
Portugal
2
Bosnia and Herzegovina
2
Greece
2
Honduras
2
Guatemala
2
Switzerland
1
Togo
1
Uzbekistan
1
Mongolia
1
Mauritania
1
Dominican Republic
1
Uruguay
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Israel
1
Latvia
1
Djibouti
1
Slovakia
1
Chad
1
Authors & Publishers
Publication Years
Category
Countries
2295
Clinical Guidelines
460
Public Health
365
Women & Child Health
284
Key Resources
186
Capacity Building
68
Pharmacy & Technologies
66
Annual Report MEDBOX
1
Toolboxes
HIV
509
Mental Health
475
COVID-19
410
TB
385
AMR
253
Planetary Health
190
Disability
182
Caregiver
170
Pharmacy
156
Rapid Response
137
Conflict
132
Ebola
123
NCDs
119
Global Health Education
108
NTDs
103
Refugee
91
Health Financing Toolbox
57
Natural Hazards
53
Specific Hazards
33
Zika
23
Polio
20
Social Ethics
18
Cholera
13
Health Financing
2
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in line with the
strategic objectives of the Glo...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution...
This updated step by step guide aims to assist the ministries of health (MoHs) in developing the national action plans for noma prevention and control, with a view to sustainably reducing the incidence of noma as a public health problem through programmes that are fully integrated with national heal...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Noma (cancrum oris) is a severe gangrenous disease of the mouth and face. It mostly affects children between the ages of 2 and 6 years living in extreme poverty. In addition to the known factors such as malnutrition, lack of vaccination in children and poor oral hygiene, several social and environme...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plans on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cost, implement, monitor and evaluate national action ...
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to these essential medicines. Enhancing access to controll...
The 2030 health-related Sustainable Development Goals call on countries to end AIDS as a public health threat and also to achieve universal health coverage. The World Health Organization (WHO) promotes primary health care (PHC) as the key mechanism for achieving universal health coverage, and the PH...
Pathogen genomic surveillance has become a priority for public health systems in recent years. Genomic sequencing is increasingly being used to characterize pathogens and monitor important public health priorities (e.g. poliovirus, influenza virus, Mycobacterium tuberculosis and Vibrio cholerae, ant...
Technology landscape
